| CITATION: | Pharmacy Board of Australia v Kent [2012] QCAT 329 |
| PARTIES: | Pharmacy Board of Australia (Applicant/Appellant) |
| v | |
| John Paul Kent (Respondent) |
| APPLICATION NUMBER: | OCR283-10 |
| MATTER TYPE: | Occupational regulation matters |
| HEARING DATE: | 24 April 2012; Final submissions received 28 May 2012 |
| HEARD AT: | Brisbane |
| DECISION OF: | Judge Fleur Kingham, Deputy President Assisted by: |
| DELIVERED ON: | 18 July 2012 |
| DELIVERED AT: | Brisbane |
| ORDERS MADE: | 1. Mr Kent’s registration is suspended for a period of 12 months. 2. That suspension order is suspended after 3 months, provided that Mr Kent must not be the subject of disciplinary action by the Tribunal for 12 months from the date of this order. 3. The details of Mr Kent’s suspension must be recorded on the Board's Register of Practitioners for 12 months from the date of this order. 4. The following conditions are imposed on Mr Kent’s registration for 12 months from the date of this order: a) Mr Kent must complete a tertiary level module in ethical decision making. b) For the purpose of condition 1 above, Mr Kent must nominate a course for the approval of the Board. c) Mr Kent must submit documentary evidence to the Board upon completion of the course. d) Mr Kent must undergo a period of mentoring of not less than 2 hours per month for 12 months from the date of this order. Such mentoring should focus upon ethical decision making in a dispensing environment. e) Mr Kent must nominate a senior pharmacist as a mentor for the approval of the Board. f) Mr Kent must authorise the mentor to provide a report in writing to the Board at the end of each quarter and at the completion of the mentoring. g) Mr Kent must bear any costs associated with the mentoring, including the provision of reports to the Board. h) Mr Kent must complete a statutory examination at the end of the period of suspension. 5. The details of the conditions imposed on Mr Kent’s registration must be recorded on the Board’s register for the period in which the conditions are in force. 6. Mr Kent must not apply to the Chief Executive, Queensland Health, under the Health (Drugs and Poisons) Regulation 1996 for reinstatement of his endorsement under section 171 of the Regulation for Testosterone, Nandrolone and Somatropin for a period of 3 years from the date of the decision. 7. Mr Kent must pay the Board's costs of and incidental to these proceedings assessed on the standard basis against the District Court scale, if not agreed. |
| CATCHWORDS: | OCCUPATIONAL REGULATION – HEALTH PRACTITIONERS – PHARMACIST – DISCIPLINARY PROCEEDINGS – Where pharmacist dispensed anabolic steroids in quantities, combinations and frequency that exceeded normal dispensing practices – where the pharmacist did not keep adequate records of dispensing practices – where the inadequacy of records did not comply with the requirements of the Health (Drugs and Poisons)Regulation 1996 – where the pharmacist engaged in an inappropriate personal relationship with a… |
Keep reading for free
Create a free CaseChat account to read Pharmacy Board of Australia v Kent and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2012] QCAT 329
- Decision Date
CaseChat Overview and Summary
The Tribunal found that Mr Kent's actions in dispensing anabolic steroids in excessive quantities and combinations fell below the expected professional standards. He failed to exercise the necessary professional judgment to prevent the supply of products that could be misused. Furthermore, his record-keeping practices did not comply with regulatory requirements, which is essential to mitigate the risk of medication misuse. The Tribunal also concluded that Mr Kent's personal relationship with a drug-dependent customer was inappropriate, particularly given his professional responsibilities towards her. The Tribunal found that these actions constituted unsatisfactory professional conduct as they fell below the standards expected by the public and professional peers, demonstrated incompetence, and provided unnecessary health services.
Considering the combination of inappropriate dispensing, record-keeping deficiencies, and the inappropriate personal relationship, the Tribunal decided on a 12-month suspension of Mr Kent's registration, suspended after 3 months, contingent on compliance with imposed conditions and no further disciplinary actions within a year. The conditions include completing a tertiary-level module in ethical decision-making, undergoing mentoring focused on ethical decision-making, and submitting to a statutory examination. Mr Kent is also prohibited from reapplying for his endorsement to dispense steroids for three years. The Tribunal ruled that these measures would uphold professional standards, maintain public confidence, and protect the public. The Tribunal further determined that Mr Kent should bear the costs of the proceedings.
In summary, the Tribunal imposed a 12-month suspension of Mr Kent's registration, subject to conditions aimed at addressing the issues of his unprofessional conduct, and prohibited him from reapplying for his endorsement for three years. The decision aimed to protect the public, uphold professional standards, and maintain public confidence in the pharmacy profession.